Access to Medical Treatment Act of 2001

openUnited States· United States Congress· EN

Introduced

3 August 2001

Last action

18 April 2002 · Introduced

Status

Sponsor introductory remarks on measure. (CR S2965)

Summary

Access to Medical Treatment Act of 2001 - Defines: (1) "danger" as an adverse reaction to an unapproved drug or medical device that used as directed causes serious harm which would not otherwise have occurred, or harm more serious than side effects for drugs or medical devices approved by the Federal Food and Drug Administration (FDA) for the same disease or condition; and (2) other terms as used in this Act, including "health care practitioner" and "unapproved drug or medical device." Allows a patient to receive, and the practitioner to provide or administer, any unapproved drug or medical device the patient or their legal representative desires, provided certain conditions are met. Sets forth circumstances under which a health care practitioner may recommend, provide, or administer an unapproved drug or medical device. Requires a practitioner who discovers that an unapproved drug or medical device creates a danger to a patient immediately to cease use and recommendation of such drug or device and provide specified information to its manufacturer and the Director of the Centers for Disease Control and Prevention. Requires the manufacturer that receives such information to: (1) immediately cease sale and distribution of the drug or device; and (2) comply with specified notification and reporting requirements. Sets forth certain investigative and reporting duties that the Director, the Secretary of Health and Human Services, and a practitioner must perform with respect to the dangerousness or effectiveness of unapproved drugs or medical devices. Sets forth a penalty for violations of this Act.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

3 August 2001
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
3 August 2001
Introduced
Sponsor introductory remarks on measure. (CR S8951-8952)
Source: IntroReferral
3 August 2001
Introduced
Introduced in Senate
Source: IntroReferral
18 April 2002
Introduced
Sponsor introductory remarks on measure. (CR S2965)
Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Introduced in Senate · 3 August 2001 · Download file

Documents

3 official files

Introduced in Senate (text)

View file Download file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Introduced in Senate (text)
Introduced in Senate · EN · 3 August 2001
View Download Open at official source
Introduced in Senate (PDF)
Introduced in Senate · EN · 3 August 2001
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate
summary · EN · 3 August 2001
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

related to → Access to Medical Treatment Act of 2001

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/107th-congress/senate-bill/1378
Open data entity: https://api.congress.gov/v3/bill/107/s/1378
us · 107-s-1378 · source updated 19 August 2025